Starton Therapeutics Announces the Opening of the First Clin

Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”...

Related Keywords

Ohio , United States , China , Delaware , Canton , Healthwell Pubco , Amy Chergey , Nash Gabrail , Healthwell Acquisition Corp , Gabrail Cancer Center , Gabrail Cancer Research Center , Exchange Commission , Starton Therapeutics Inc , Holdings Corp , Gabrail Cancer , Research Center , Starton Therapeutics , Executive Director Clinical Operations , About Starton , Combination Agreement , Registration Statement , Healthwell Acquisition , Business Combination Agreement , Annual Report , While Starton , Securities Act ,